Context Therapeutics
CNTX
#10813
Rank
A$22.2 M
Marketcap
A$0.24
Share price
-5.10%
Change (1 day)
-85.68%
Change (1 year)

EPS for Context Therapeutics (CNTX)

EPS in 2026 (TTM): A-$0.64

According to Context Therapeutics's latest financial reports the company's current EPS (TTM) is A-$0.65. In 2025 the company made an earnings per share (EPS) of A-$0.57 an increase over its 2024 EPS that were of A-$0.69.

EPS history for Context Therapeutics from 2019 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$0.6410.63%
2025A-$0.57-17.39%
2024A-$0.69-69.33%
2023A-$2.2761.29%
2022A-$1.41-74.8%
2021A-$5.57-3617.97%
2020A$0.16-116.77%
2019A-$0.94